Materiały źródłowe

• #1 Fibrocystic Breast Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK551609/

  Fibrocystic breast disease is the most common benign type of breast disease, diagnosed in millions of women worldwide. […] There is varied literature, ranging from 30 to 60% of all women. It is most common in women between the ages of 30 to 50 years. […] One of the most common forms of benign breast disease is fibroadenomas, characterized by localized proliferation of breast ducts and stroma. This subtype accounts for 70 to 95% of all tumor benign type of breast disease. The incidence is mostly seen in the 17 to 20 year age group, extending to 2 years premenarche at 35.

• #1 Fibrocystic breast changes – Wikipedia

  https://en.wikipedia.org/wiki/Fibrocystic_breast_changes

  The estimated prevalence of fibrocystic breast changes in women over their lifetime varies widely in the literature, ranging from 30 to 60% over about 50 to 60% to about 60 to 75% of all women. […] The condition is most common among women between 30 and 50 years of age.

• #1 Fibrocystic change (breast) | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/9057?embed_domain=hackmd.io%2F%40yipuafecsl2jsu8smr5njq%2Fbnjhjgjghjghjghfavicon.icoradiopaedia-icon-144.pngfavicon.icofavi

  Fibrocystic changes are a prevalent condition, observed clinically in up to 50% of women and histologically in 90% of cases. […] These changes are uncommon before adolescence and are most frequently diagnosed between the ages of 20 and 40, with incidence peaking around menopause. […] In comparison to the general population, women with nonproliferative lesions do not exhibit a significant increase in the risk of developing breast carcinoma. However, those with proliferative disease have an elevated risk.

• #1 Breast Cyst – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562196/

  Many studies report a high lifetime prevalence of fibrocystic breast disease in women, showing that over 70% of all women develop fibrocystic changes during their lives, with 20% of these women being symptomatic and 10%-30% developing sclerosing adenosis. […] It is thought that 7% of all women in the United States will develop a palpable breast cyst at some point in their life. Breast cysts typically develop in 30 to 50-year-old females. The incidence of cyst development increases throughout these years then drops dramatically afterward. As cyst development is related to hormone levels in the body, most benign cysts disappear, and new cysts stop developing a year after menopause.

• #1 Fibrocystic Breast Condition Epidemiology Forecast 2034

  https://www.expertmarketresearch.com/epidemiology-reports/fibrocystic-breast-condition-epidemiology-forecast

  It is estimated that approximately 50% of women between the ages of 20 and 50 undergo fibrocystic breast changes. Symptoms of this condition are reported to fluctuate with the menstrual cycle or other hormonal changes. Fibrocystic breast condition is more common before menopause. […] The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of fibrocystic breast condition in the 8 major markets. […] Fibrocystic breast changes are reported in 50% of the women between the ages of 20 and 50. […] Fibrocystic breast disease is the most common benign breast condition, affecting millions of women globally. In the Womens Health Initiative (WHI) study, the combined use of estrogen and progestin was associated with a 74% increased risk of developing benign breast disease.

• #1 Fibrocystic breasts: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/000912.htm

  Fibrocystic breasts are painful, lumpy breasts. Formerly called fibrocystic breast disease, this common condition is, in fact, not a disease. Many women experience these normal breast changes, usually around their period. […] More than half of women have this condition at some time during their life. It is most common between the ages of 30 and 50. It is rare in women after menopause unless they are taking estrogen. Fibrocystic breast changes do not change your risk for breast cancer. […] If your breast exams and mammograms are normal, you do not need to worry about your symptoms. Fibrocystic breast changes do not generally increase your risk for breast cancer. However, if you have a family history of breast cancer and fibrocystic changes, there is a small increase in the risk. Symptoms usually improve after menopause.

• #1 Overview of common breast conditions – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/overview-of-common-breast-conditions/

  Fibrocystic breast changes [1][10] […] Most common benign breast condition. […] Premenstrual breast tenderness. […] Multiple breast nodules bilaterally. […] Age-appropriate imaging of a palpable breast mass: ultrasound and/or mammography [1] […] Distorted breast parenchyma, scattered coarse calcifications [11][12]. […] Clustered microcysts, simple breast cysts, complicated breast cysts [12][13][14][15]. […] Concern for malignancy: image-guided core needle biopsy [16]. […] Symptomatic management. […] Proliferative breast lesions with atypia: surgical excision followed by close surveillance for breast cancer [1]. […] […] […] Benign breast conditions most commonly affect women between the third and fifth decades of life. […] […] […] Peak incidence: 35-50 years of age.

• #1 Breast diseases: Detection, Management, and Surveillance of Breast Disease | Obgyn Key

  https://obgynkey.com/breast-diseases-detection-management-and-surveillance-of-breast-disease/

  Fibrocystic changes represent an exaggeration of the normal physiologic response of breast tissue to the cyclic levels or ovarian hormones. These changes, unusual in adolescence, are most common in women of reproductive age (20 to 50 years) and unusual after menopause unless associated with exogenous hormone replacement. […] The incidence of benign breast disorders begins to rise during the second decade of life and peaks in the fourth and fifth decades. In malignant diseases the incidence continues to increase after menopause. […] The role of the gynecologist in the management of breast disease has been addressed in a number of published clinical opinions and practice bulletins from the American College of Obstetrics and Gynecology. The role of the gynecologist, with shared decision making, includes the following: Compiling a comprehensive personal and family history in an effort to identify risk factors and institute care accordingly.

• #1 Breast lumps epidemiology and demographics – wikidoc

  https://www.wikidoc.org/index.php/Breast_lumps_epidemiology_and_demographics

  The incidence rate of fibrocystic disease is 137 per 100,000 in women aged 25-29 years, 411 per 100,000 in age of 40-44 years and 387 per 100,000 in 45-49 years. […] Fibrocystic disease, phyllodes tumor, and adenomyoepithelioma are usually seen in 3rd and 4th decade of life. […] African American women have worse prognosis and higher mortality rate in comparison to European American women.

• #1 Fibrocystic breasts – UF Health

  https://ufhealth.org/conditions-and-treatments/fibrocystic-breasts

  More than half of women have this condition at some time during their life. It is most common between the ages of 30 and 50. It is rare in women after menopause unless they are taking estrogen. Fibrocystic breast changes do not change your risk for breast cancer. […] If your breast exams and mammograms are normal, you do not need to worry about your symptoms. Fibrocystic breast changes do not generally increase your risk for breast cancer. However, if you have a family history of breast cancer and fibrocystic changes, there is a small increase in the risk.

• #1 Fibrocystic breast changes

  https://en-academic.com/dic.nsf/enwiki/11540276

  Fibrocystic breast changes or fibrocystic breast disease is a condition of breast tissue affecting an estimated 30-60% of women. […] The causes of the condition are not fully understood, though it is known that they are tied to hormone levels, as the condition usually subsides after menopause and is also related to the menstrual cycle. […] Diagnosis is mostly done based on symptoms after exclusion of breast cancer. […] Breast cancer risk is elevated for small fraction of lesions. Nonproliferative lesions have no increased risk, proliferative lesions approximately 2-fold risk. Atypical lobular hyperplasia is associated with the greatest risk, approximately 5-fold and especially high relative risk of developing premenopausal breast cancer. […] It is not well understood whether the lesions are precursors of breast cancer or only indication of increased risk, for most types of lesions the chance of developing breast cancer is nearly the same in the affected and unaffected breast (side) indicating only coincidence of risk factors.

• #1 Fibrocystic breast changes – Knowledge @ AMBOSS

  https://www-amboss-com.bibliotecavirtual.udla.edu.ec/us/knowledge/fibrocystic-breast-changes/

  Fibrocystic breast changes is a nonspecific term that includes a heterogeneous spectrum of breast conditions. Women between 20 and 50 years of age are most commonly affected. […] Most common benign lesion of the breast. […] Up to 50% of women are affected during their lifetime. […] Epidemiological data refers to the US, unless otherwise specified. […] Atypical ductal hyperplasia is associated with an increased risk of breast cancer in both the affected and contralateral breast. […] Proliferative breast lesions with atypical cells (e.g., ductal epithelial hyperplasia) are associated with an increased risk of cancer.

• #1 Fibrocystic Breast Disease: Causes, Symptoms, and Diagnosis

  https://www.healthline.com/health/fibrocystic-breast-disease

  Fibrocystic breast disease can cause the breasts to feel lumpy. While it isnt associated with an increased breast cancer risk, it may make it more difficult to identify lumps due to breast cancer. […] According to the Mayo Clinic, more than half of women will develop fibrocystic breast disease at some point in their lives. […] Although it isnt harmful to have fibrocystic breasts, this condition can make the detection of breast cancer more challenging. […] Fibrocystic breast disease doesnt increase your risk of getting cancer, but the changes in your breasts can make it more difficult for you or your doctor to identify potentially cancerous lumps during breast exams and on mammograms. […] The U.S. Preventive Services Task Force recommends that women between 50 and 74 years old get a mammogram every two years. […] Its important that you become familiar with how your breasts look and feel normally so that youll know when there are changes or something doesnt seem right.

• #1 Fibrocystic Breast Condition Epidemiology Forecast 2034

  https://www.expertmarketresearch.com/epidemiology-reports/fibrocystic-breast-condition-epidemiology-forecast

  The fibrocystic breast condition epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. […] The epidemiology of fibrocystic breast condition varies significantly between countries due to differences in the prevalence of risk factors, dietary habits, healthcare access, breast health awareness, genetic predispositions to breast conditions, and exposure to environmental factors, such as endocrine-disrupting chemicals or pollutants, among others.

• #1 Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series | British Journal of Cancer

  https://www.nature.com/articles/bjc1991218

  The relationship of reproductive factors, such as nulliparous vs ever-parous status, age at first birth, and total parity, with morphologic prevalence of fibrocystic changes were examined using autopsy material from three ethnic/racial groups at varying risks for breast cancer. […] Although there was a trend toward a protective effect of ever-parous status, there was no statistically significant difference in the prevalence of fibrocystic disease in any group defined by parity status. […] The ethnic differences in the prevalence of fibrocystic changes were not explained by the differences in parity status distribution for the three ethnic/racial groups.

• #1 Fibrocystic Breast Condition – Epidemiology Forecast – 2032

  https://www.researchandmarkets.com/reports/5525305/fibrocystic-breast-condition-epidemiology?srsltid=AfmBOopq4oPhqMJaTtey1Tfv_MyyBPFJ9Y5T0qloMP6f5kyYr3oRO3zi

  The Fibrocystic Breast Condition epidemiology report gives a thorough understanding of the Fibrocystic Breast Condition by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Fibrocystic Breast Condition in the US, Europe, and Japan. The report covers the detailed information of the Fibrocystic Breast Condition epidemiology scenario in seven major countries (US, EU5, and Japan). […] The Fibrocystic Breast Condition epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Fibrocystic Breast Condition epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Fibrocystic Breast Condition epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

• #1 Fibrocystic Breast Condition – Epidemiology Forecast – 2032

  https://www.researchandmarkets.com/reports/5525305/fibrocystic-breast-condition-epidemiology?srsltid=AfmBOopq4oPhqMJaTtey1Tfv_MyyBPFJ9Y5T0qloMP6f5kyYr3oRO3zi

  The Fibrocystic Breast Condition epidemiology covered in the report provides historical as well as forecasted Fibrocystic Breast Condition epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032. The Fibrocystic Breast Condition report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

• #1 Fibrocystic Breasts: Treatment, Pain, & Menopause

  https://www.medicinenet.com/fibrocystic_breast_condition/article.htm

  Fibrocystic breast condition primarily affects women 30 years of age and older. The reason for this is that the condition likely results from a cumulative process of repeated monthly hormonal cycles and the accumulation of fluid, cells, and cellular debris within the breast. […] Fibrocystic breast condition that involves hyperplasia is associated with a slightly elevated risk of breast cancer, and atypical hyperplasia is associated with a moderately increased risk of breast cancer when compared to women without fibrocystic changes. […] The basic problem with fibrocystic breast condition is the threat of breast cancer. Fibrocystic breast condition is itself benign (non-cancerous) and exceedingly common. Additionally, breast cancer is a common malignancy in women. Both conditions, one benign and the other a leading cause of cancer deaths in women, involve the same organ—the breast—and both can involve the presence of breast masses. […] If a woman’s breasts are fibrocystic, other diagnostic tests in addition to screening mammography may be necessary in order to rule out an underlying breast cancer.

• #1 Breast diseases: Detection, Management, and Surveillance of Breast Disease | Obgyn Key

  https://obgynkey.com/breast-diseases-detection-management-and-surveillance-of-breast-disease/

  Breast cancer continues to be the most commonly diagnosed cancer in women worldwide. It is caused by a progressive accumulation of mutations in the cells DNA. Epidemiologic studies help identify factors that through either exposure or inheritance place a woman at risk for a greater chance of cellular change. Approximately 50% of newly diagnosed breast cancers are attributable to known risk, whereas 10% are associated with simply a positive family history.

• #1 Managing Fibrocystic Breast Changes and Pain: Perspectives for the Pharmacist

  https://www.pharmacytimes.com/view/r703_april2015

  Fibrocystic breast changes (FBC) occur in approximately 50% of women of childbearing age, and some studies indicate that the lifetime prevalence of FBC may be as high as 70% to 90%. […] Management of FBC is currently nonstandardized, as there are no established US guidelines for treatment of symptoms of this condition. […] Pharmacists can help patients with FBC by explaining that FBC is a treatable condition and encouraging active management.

• #2 Fibrocystic breasts: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/000912.htm

  Fibrocystic breasts are painful, lumpy breasts. Formerly called fibrocystic breast disease, this common condition is, in fact, not a disease. Many women experience these normal breast changes, usually around their period. […] More than half of women have this condition at some time during their life. It is most common between the ages of 30 and 50. It is rare in women after menopause unless they are taking estrogen. Fibrocystic breast changes do not change your risk for breast cancer. […] If your breast exams and mammograms are normal, you do not need to worry about your symptoms. Fibrocystic breast changes do not generally increase your risk for breast cancer. However, if you have a family history of breast cancer and fibrocystic changes, there is a small increase in the risk. Symptoms usually improve after menopause.

• #2 Fibrocystic Breast Changes – Life Extension

  https://www.lifeextension.com/protocols/female-reproductive/fibrocystic-breast-changes?srsltid=AfmBOooHrFQ2__GEhP9QS8HR3K0r7H1Tx3nSK_fzHkorjvcNK0uGWWyf

  Fibrocystic breast changes are non-cancerous lumps or abnormalities in the breast tissue. Between 50% and 90% of women will experience benign changes in their breast tissue during their lifetime, with 30s and 40s being the most common age of occurrence. […] Fibrocystic breast changes are non-cancerous (benign) lumps or abnormalities in the breast tissue. Fibrocystic breasts are very common: estimates suggest that between 50% and 90% of all women will experience benign changes in their breast tissue during their lifetime. […] Some types of fibrocystic breast changes are associated with a small increase in breast cancer risk, particularly when there is a family history of breast cancer. However, fibrocystic changes are often not associated with an increased risk of breast cancer. […] The incidence of benign breast abnormalities peak in women’s 30s and 40s. This is in contrast to risk of breast cancer, which continues to increase after menopause.

• #2 Examining the Associations among Fibrocystic Breast Change, Total Lean Mass, and Percent Body Fat | Scientific Reports

  https://www.nature.com/articles/s41598-018-27546-3

  Fibrocystic breast change (FBC) is extremely common and occurs in 90% of women during their lives. […] Several studies indicated that the lifetime prevalence of FBC in women might be as high as 70% to 90%. […] However, accumulating evidence has proposed that the breast cancer risk is involved with FBC. […] In conclusion, increased PBF and reduced TLM were likely to predict the risk of the presence of FBC in a general female population. […] Our findings highlighted the associations of TLM and PBF with the presence of FBC in a general female population.

• #2 Breast diseases: Detection, Management, and Surveillance of Breast Disease | Obgyn Key

  https://obgynkey.com/breast-diseases-detection-management-and-surveillance-of-breast-disease/

  Fibrocystic changes represent an exaggeration of the normal physiologic response of breast tissue to the cyclic levels or ovarian hormones. These changes, unusual in adolescence, are most common in women of reproductive age (20 to 50 years) and unusual after menopause unless associated with exogenous hormone replacement. […] The incidence of benign breast disorders begins to rise during the second decade of life and peaks in the fourth and fifth decades. In malignant diseases the incidence continues to increase after menopause. […] The role of the gynecologist in the management of breast disease has been addressed in a number of published clinical opinions and practice bulletins from the American College of Obstetrics and Gynecology. The role of the gynecologist, with shared decision making, includes the following: Compiling a comprehensive personal and family history in an effort to identify risk factors and institute care accordingly.

• #2 Fibrocystic Breast Disease – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK551609/

  Fibrocystic breast disease is the most common benign type of breast disease, diagnosed in millions of women worldwide. […] There is varied literature, ranging from 30 to 60% of all women. It is most common in women between the ages of 30 to 50 years. […] One of the most common forms of benign breast disease is fibroadenomas, characterized by localized proliferation of breast ducts and stroma. This subtype accounts for 70 to 95% of all tumor benign type of breast disease. The incidence is mostly seen in the 17 to 20 year age group, extending to 2 years premenarche at 35.

• #2 Fibrocystic breasts – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/fibrocystic-breasts/symptoms-causes/syc-20350438

  Fibrocystic breast changes occur most often between 30 and 50 years of age. These changes happen rarely after menopause unless you’re taking hormone replacement medicine such as estrogen or progesterone. […] The exact cause of fibrocystic breast changes isn’t known, but experts suspect that reproductive hormones especially estrogen play a role. […] Having fibrocystic breasts doesn’t increase your risk of breast cancer.

• #2 Fibrocystic breasts – Symptoms, diagnosis and treatment | BMJ Best Practice US

  https://bestpractice.bmj.com/topics/en-us/1003

  Fibrocystic breasts are characterized by „lumpy” breasts associated with pain and tenderness that fluctuate with the menstrual cycle. […] Assessment of risk for the development of breast cancer is important and is useful in patient reassurance or to design risk reduction strategies. […] These changes do not correlate with an increased risk of breast cancer; fibrocystic changes of the breast reflect a broad spectrum of conditions that carry different risks for future development of breast cancer.

• #2 Fibrocystic Changes in the Breast | Fibrosis and Cysts | American Cancer Society

  https://www.cancer.org/cancer/types/breast-cancer/non-cancerous-breast-conditions/fibrosis-and-simple-cysts-in-the-breast.html

  Fibrocystic changes are most common in women of child-bearing age, but they can affect women of any age. […] Neither fibrosis nor simple cysts increase your risk of later developing breast cancer. […] There is a small chance complicated cysts and complex cystic and solid masses might contain cancer or put you at higher risk of breast cancer later on, depending on what is found on a biopsy.

• #2 Fibrocystic breast changes

  https://en-academic.com/dic.nsf/enwiki/11540276

  Fibrocystic breast changes or fibrocystic breast disease is a condition of breast tissue affecting an estimated 30-60% of women. […] The causes of the condition are not fully understood, though it is known that they are tied to hormone levels, as the condition usually subsides after menopause and is also related to the menstrual cycle. […] Diagnosis is mostly done based on symptoms after exclusion of breast cancer. […] Breast cancer risk is elevated for small fraction of lesions. Nonproliferative lesions have no increased risk, proliferative lesions approximately 2-fold risk. Atypical lobular hyperplasia is associated with the greatest risk, approximately 5-fold and especially high relative risk of developing premenopausal breast cancer. […] It is not well understood whether the lesions are precursors of breast cancer or only indication of increased risk, for most types of lesions the chance of developing breast cancer is nearly the same in the affected and unaffected breast (side) indicating only coincidence of risk factors.

• #2 Fibrocystic Breasts: Causes, Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/22080-fibrocystic-breasts

  Fibrocystic breasts are a common, noncancerous condition that causes painful, lumpy breast tissue. Up to 50% of all females between ages 20 and 50 experience fibrocystic breast changes. […] Fibrocystic breasts can affect anyone, but its most common in before menopause. Its rare to have fibrocystic breast changes after menopause unless youre taking hormone replacement therapy. […] There arent any studies that show fibrocystic breast changes increase your risk for cancer or contribute to breast cancer. The only correlation is that it might be harder to spot precancerous or worrisome breast tissue in fibrocystic breasts. […] Your risk for breast cancer isnt any higher if you have fibrocystic breasts. But changes in your breast tissue from fibrocystic breasts could make it slightly harder to detect tissue that may be cancerous.

• #2 Fibrocystic Breast Condition – Epidemiology Forecast – 2032

  https://www.researchandmarkets.com/reports/5525305/fibrocystic-breast-condition-epidemiology?srsltid=AfmBOopq4oPhqMJaTtey1Tfv_MyyBPFJ9Y5T0qloMP6f5kyYr3oRO3zi

  The Fibrocystic Breast Condition epidemiology covered in the report provides historical as well as forecasted Fibrocystic Breast Condition epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032. The Fibrocystic Breast Condition report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

• #2 Fibrocystic Breast Condition Epidemiology Forecast 2034

  https://www.expertmarketresearch.com/epidemiology-reports/fibrocystic-breast-condition-epidemiology-forecast

  The fibrocystic breast condition epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. […] The epidemiology of fibrocystic breast condition varies significantly between countries due to differences in the prevalence of risk factors, dietary habits, healthcare access, breast health awareness, genetic predispositions to breast conditions, and exposure to environmental factors, such as endocrine-disrupting chemicals or pollutants, among others.

• #2 Fibrocystic Breast Disease: Causes, Symptoms, and Diagnosis

  https://www.healthline.com/health/fibrocystic-breast-disease

  Fibrocystic breast disease can cause the breasts to feel lumpy. While it isnt associated with an increased breast cancer risk, it may make it more difficult to identify lumps due to breast cancer. […] According to the Mayo Clinic, more than half of women will develop fibrocystic breast disease at some point in their lives. […] Although it isnt harmful to have fibrocystic breasts, this condition can make the detection of breast cancer more challenging. […] Fibrocystic breast disease doesnt increase your risk of getting cancer, but the changes in your breasts can make it more difficult for you or your doctor to identify potentially cancerous lumps during breast exams and on mammograms. […] The U.S. Preventive Services Task Force recommends that women between 50 and 74 years old get a mammogram every two years. […] Its important that you become familiar with how your breasts look and feel normally so that youll know when there are changes or something doesnt seem right.

• #2 Overview of common breast conditions – Knowledge @ AMBOSS

  https://www.amboss.com/us/knowledge/overview-of-common-breast-conditions/

  […] […] Breast cysts [1][17][18] […] Single or multiple breast masses. […] Variable size (microcysts, gross cyst, clusters) and texture (smooth, soft, firm). […] May be tender. […] Usually mobile. […] Ultrasound is preferred. [1][16] […] Simple breast cyst. […] Complicated breast cyst. […] Complex breast cyst. […] Concern for malignancy: image-guided biopsy. […] Simple breast cysts: no intervention needed unless symptomatic [1][3]. […] Complicated breast cysts: surveillance or biopsy [1]. […] Complex breast cysts: biopsy [1][17][18] […] Benign: surveillance. […] Malignant: surgical excision.

• #2 Fibrocystic Breast Changes – Life Extension

  https://www.lifeextension.com/protocols/female-reproductive/fibrocystic-breast-changes?srsltid=AfmBOooHrFQ2__GEhP9QS8HR3K0r7H1Tx3nSK_fzHkorjvcNK0uGWWyf

  Alcohol intake during adolescence and early adulthood increases risk of proliferative benign breast conditions. […] Fibrocystic changes occur in at least half of women and are uncommonly associated with the development of breast cancer. However, the primary importance of diagnosing benign breast disease is to rule out more serious conditions, including breast cancer. […] Unfortunately, benign breast conditions are often misdiagnosed since each woman’s breast anatomy is different and mammography cannot identify all structures with complete precision. Thus, a woman with a benign breast lump may need other diagnostic procedures potentially including ultrasound, aspiration, and biopsy to exclude malignancy. […] The precise cause of fibrocystic changes is not known, but hormonal imbalances are strongly implicated as a contributing factor. A relative deficiency of progesterone or excess of estrogen during the luteal phase of the menstrual cycle may lead to fibrocystic changes. […] Dietary factors appear to play an important role in the development of both benign fibrocystic changes and breast cancer, and specific components of a healthy diet may significantly reduce the risk of developing fibrocystic changes and benign breast disease.

• #2 Fibrocystic Breast Condition – Epidemiology Forecast – 2032

  https://www.researchandmarkets.com/reports/5525305/fibrocystic-breast-condition-epidemiology?srsltid=AfmBOopq4oPhqMJaTtey1Tfv_MyyBPFJ9Y5T0qloMP6f5kyYr3oRO3zi

  The Fibrocystic Breast Condition epidemiology report gives a thorough understanding of the Fibrocystic Breast Condition by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Fibrocystic Breast Condition in the US, Europe, and Japan. The report covers the detailed information of the Fibrocystic Breast Condition epidemiology scenario in seven major countries (US, EU5, and Japan). […] The Fibrocystic Breast Condition epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Fibrocystic Breast Condition epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Fibrocystic Breast Condition epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Zobacz więcej